Taken together, the above findings demonstrated that GSCs overexpressing miR-26a could potentially enhance angiogenesis of HBMECs and tumor growth of nude mice, down-regulate PTEN expression and up-regulate VEGF expression. The gene discussed is VEGFA; the disease is neoplasm.